The Middle East and Africa Ventricular Assist Device market touched USD xx million in 2018, and is expected to reach USD xx million by 2025, growing at a CAGR of 11.2% during 2018-2025.
- The Ventricular Assist Device market is driven by the factors such as:
- Transition to minimally invasive surgical procedure from conventional surgeries
- Improving healthcare infrastructure in Middle East and Africa
- Shortage of heart donors
- Introduction of new technological advanced products in the region
Middle East and African Ventricular Assist Device market is expanding due to increase in healthcare expenditure in the region and increase in awareness regarding cardiac devices. Additionally, advancement in LVAD implantation technology and increasing number of heart failures have contributed to the market growth
According to GMI Research, Bridge-to-transplant Application segment held the maximum revenue share in 2017 because of increasing rate of heart failures in the region and rising number of patients waiting for heart transplant. However, the Bride-to-recovery segment is expected to get more traction in the forecast period due to increase in number of heart donors.
Left Ventricular Assist Device segment held the maximum revenue share in the device segment in 2017 and is expected to hold its dominance in the Middle East and Africa region in the forecast period, owing to product advancement and majorly damaging of left ventricle in the heart failure.
GMI Research expects, Transcutaneous design type is estimated to have the highest growth rate in the forecast period owing to its advanced specifications. Implantable design type segment held the maximum revenue share in 2017 and is expected to do so in the forecast period due to its wide popularity in the region and its cost effectiveness.
The major players are focusing on product launches, spreading awareness regarding the cardiac diseases and their treatment through campaigns and collaborating with healthcare facilities to keep leadership in the competitive Middle East and Africa Ventricular Assist Device—-GMI Research
- Key takeaways/key essentials:
- In 2018, the Bridge-to-transplant application segment held the maximum revenue share in 2017 and will continue to do so in the forecast period.
- Transcutaneous design type is expected to grow at the fastest rate in the forecast period.
- Left ventricular assist device is being used the most in the region as the heart failure is mainly caused by the left ventricular malfunctioning.
Various notable players operating in Middle East and Africa Ventricular Assist Device Market are Berlin Heart GmbH, Cardiac Assist, Inc. (LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed among others.
The Middle East and Africa Ventricular Assist Device market has been segmented on the basis of Type, Application, and Design Segmentation. Based on Type, the market comprises of Left Ventricular Device, Right Ventricular Device and Biventricular Device. The Application type includes Bridge-to-transplant (BTT), Bridge-to-recovery (BTR) and Destination Therapy and the Design type includes Implantable Ventricular Assist and Transcutaneous Ventricular Assist Devices
The research report “Middle-East and Africa Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, in Middle East and Africa, based on application type, design type and type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
For more details, Please Visit: https://www.gmiresearch.com/report/middle-east-and-africa-ventricular-assist-device-market-mea-vad/
Early buyers will get customization upto 25% on report
Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820